MARSHALL WACE, LLP - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 43 filers reported holding EVELO BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q3 2021$273,000
-68.3%
38,807
-38.0%
0.00%
-75.0%
Q2 2021$861,000
-46.3%
62,602
-58.2%
0.00%
-42.9%
Q1 2021$1,603,000
+220.6%
149,926
+262.4%
0.01%
+133.3%
Q4 2020$500,000
+1215.8%
41,375
+567.6%
0.00%
Q3 2019$38,0006,1980.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q3 2019
NameSharesValueWeighting ↓
Mayo Clinic 479,242$6,585,0007.28%
Flagship Pioneering Inc. 23,030,069$316,433,0004.04%
HARBOURVEST PARTNERS LLC 3,063,505$42,093,0004.02%
Trustees of Columbia University in the City of New York 113,850$1,564,0002.31%
Alphabet Inc. 1,060,495$14,571,0000.30%
Artal Group S.A. 1,000,000$13,740,0000.28%
Larson Financial Group LLC 31,354$431,0000.10%
Virtus ETF Advisers LLC 13,690$188,0000.08%
STATE OF MICHIGAN RETIREMENT SYSTEM 900,000$12,366,0000.07%
CREDIT SUISSE AG/ 3,095,719$42,536,0000.02%
View complete list of EVELO BIOSCIENCES INC shareholders